Atopic dermatitis
Conditions
Interventions
The test article (Pure Golden Jojoba Oil) shall be topically applied to the unilaterally assigned area on either the forearm or lower leg, twice per day (in the morning and evening), for a duration of
Sponsors
Non-Profit Organization Health Institute Research of Skin
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years or older with atopic dermatitis. 2. Patients with AD who have maintained a remission state*1 for at least four weeks. *1 Definition of remission: The overall condition remains stable with an IGA score of 0 or 1. The remission state can be maintained mainly with moisturizers, while anti-inflammatory topical agents*2 are used only on limited areas of the body. The use of oral JAK inhibitors or biologics is permitted. *2 Anti-inflammatory topical agents- topical corticosteroids, tacrolimus ointment, delgocitinib ointment, difamilast ointment, and tapinarof cream. 3. Patients presenting with comparable skin dryness on both sides of the lower legs or forearms -evaluation sites. Selection of Evaluation Sites Both the left and right sides of either the lower legs or forearms will be designated as evaluation sites. The application site and the non-application site of the test product will be randomly assigned to the left or right side. If dryness is observed on both the lower legs and forearms, the lower legs will be selected as the evaluation sites.
Exclusion criteria
Exclusion criteria: Patients with inflammation at the evaluation site who are using anti-inflammatory topical medications Patients with a history of contact dermatitis to cosmetics or similar products Other patients deemed ineligible for the study by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the Skin Dryness Score between the test-applied and non-applied sides at Week 4. | — |
Countries
Japan
Contacts
Public ContactAyako Fukase
EBC&M LLC Scientific Planning Department
Outcome results
None listed